Taste Test of a New Formulation of Sildenafil (Revatio)
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT00768573
Collaborator
(none)
4
1
Study Details
Study Description
Brief Summary
taste of formulation
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Detailed Description
taste test None
Study Design
Study Type:
Observational
Actual Enrollment
:
4 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
A Single-Blind Study In Healthy Adult Volunteers To Investigate The Palatability Of Different Oral Suspension Formulations Of Revatio®
Study Start Date
:
Jan 1, 2008
Actual Primary Completion Date
:
Jan 1, 2008
Actual Study Completion Date
:
Jan 1, 2008
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
1. Taste test
|
Drug: sildenafil
Oral suspension of sildenafil.
|
Outcome Measures
Primary Outcome Measures
- palatability (aroma, flavour texture and mouth feel) [Duration of study.]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
- Healthy
Exclusion Criteria:
- History of hypersensitivity to test compounds or excipients.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Pfizer Investigational Site | Cambridge | Massachusetts | United States | 02140 |
Sponsors and Collaborators
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Investigators
- Study Director: Pfizer CT.gov Call Center, Pfizer
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.Responsible Party:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
ClinicalTrials.gov Identifier:
NCT00768573
Other Study ID Numbers:
- A1481257
First Posted:
Oct 8, 2008
Last Update Posted:
Feb 1, 2021
Last Verified:
Jan 1, 2021
Keywords provided by Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Additional relevant MeSH terms: